Vesicular monoamine transporter-2: Immunogold localization in striatal axons and terminals

被引:0
|
作者
Nirenberg, MJ
Chan, J
Liu, YJ
Edwards, RH
Pickel, VM
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143
关键词
ultrastructure; dopamine; caudate-putamen; synaptic vesicle; densecore vesicle;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The vesicular monoamine transporter-2 (VMAT2) mediates the reserpine-sensitive neuronal uptake of monoamines into vesicles and other intracellular organelles. Accordingly, this transporter is expressed at high levels in regions that contain a dense monoamine innervation, such as the rat dorsolateral striatum. We used ultrastructural immunocytochemistry in this region to show that immunogold labeling for VMAT2 is present in varicose axonal processes, many of which also contain the catecholamine-synthesizing enzyme tyrosine-hydroxylase. Within these mainly dopaminergic processes, VMAT2 was associated with small synaptic vesicles (SSVs) and more rarely with large dense-core vesicles or tubulovesicles. These findings suggest that SSVs are the major organelles involved in the storage and release of dopamine in the dorsolateral striatum. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:194 / 198
页数:5
相关论文
共 50 条
  • [41] In vitro assessment of dopamine uptake and methamphetamine-induced dopamine efflux at the vesicular monoamine transporter-2
    Volz, TJ
    Hanson, GR
    Fleckenstein, AE
    FASEB JOURNAL, 2006, 20 (04): : A684 - A684
  • [42] GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamine
    Horton, David B.
    Nickell, Justin R.
    Zheng, Guangrong
    Crooks, Peter A.
    Dwoskin, Linda P.
    JOURNAL OF NEUROCHEMISTRY, 2013, 127 (02) : 177 - 186
  • [43] Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles
    Volz, Trent J.
    Farnsworth, Sarah J.
    King, Jill L.
    Riddle, Evan L.
    Hanson, Glen R.
    Fleckenstein, Annette E.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 323 (02): : 738 - 745
  • [44] MELATONIN ATTENUATES AMPHETAMINE-INDUCED DECREASE IN VESICULAR MONOAMINE TRANSPORTER-2 IN POSTNATAL RAT STRIATUM
    Mukda, S.
    Govitrapong, P.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 39 - 39
  • [45] Risperidone, an atypical antipsychotic, affects the mRNA expressions of monoamine oxidase type B and vesicular monoamine transporter-2 in rat brain
    Ota, M
    Nakashima, A
    Mori, K
    Hamanaka, T
    Ota, A
    BIOGENIC AMINES, 1999, 15 (02) : 197 - 216
  • [46] 1,4-Diphenalkylpiperidines: A new scaffold for the design of potent inhibitors of the vesicular monoamine transporter-2
    Nickell, Justin R.
    Culver, John P.
    Janganati, Venumadhav
    Zheng, Guangrong
    Dwoskin, Linda P.
    Crooks, Peter A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (13) : 2997 - 3000
  • [47] Lobelane Inhibits Methamphetamine-Evoked Dopamine Release via Inhibition of the Vesicular Monoamine Transporter-2
    Nickell, Justin R.
    Krishnamurthy, Sairam
    Norrholm, Seth
    Deaciuc, Gabriela
    Siripurapu, Kiran B.
    Zheng, Guangrong
    Crooks, Peter A.
    Dwoskin, Linda P.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 332 (02): : 612 - 621
  • [48] GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine
    Lee, Na-Ra
    Zheng, Guangrong
    Leggas, Markos
    Janganati, Venumadhav
    Nickell, Justin R.
    Crooks, Peter A.
    Bardo, Michael T.
    Dwoskin, Linda P.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 371 (02): : 526 - 543
  • [49] Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture
    Yamamoto, Hideko
    Kamegaya, Etsuko
    Hagino, Yoko
    Imai, Kazuhide
    Fujikawa, Akihiro
    Tamura, Kohei
    Enokiya, Tomoyuki
    Yamamoto, Toshifumi
    Takeshima, Takao
    Koga, Hisashi
    Uhl, George R.
    Ikeda, Kazutaka
    Sora, Ichiro
    NEUROCHEMISTRY INTERNATIONAL, 2007, 51 (2-4) : 237 - 244
  • [50] Cocaine effects on striatal dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) protein in humans
    Oakman, S
    Zhang, L
    Maddox, R
    Little, KY
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 130S - 130S